
Leadership
Better Lives for Patients and Families Living with Duchenne Muscular Dystrophy
StrongHolt Therapeutics has assembled a seasoned management team with broad and deep expertise in gene therapy discovery and development, neuromuscular disease treatment and management, regulatory and clinical trial execution, and building successful companies in the Life Sciences.
StrongHolt Leadership
-
Hansell H. Stedman
Co-Founder
-
Charles R. Bridges
Co-Founder
-
G. Russell Reiss
COO
We are Focused on Delivering Life-Changing Therapies to Patients and Families Living with DMD.